Latest Breaking News On - Small pharma inc - Page 7 : comparemela.com

Cybin (CYBN) Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study

Cybin (CYBN) Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesDoug drysdaleCarol routledgeGabriel fahelGeorge tzirasHealth canadaExchange commissionNeither the neo exchange incSmall pharma incCybin incRegulatory agencyDrug administrationSmall pharmaMajor depressive disorderChief executive officer

DMT-SSRI combination shows potential for depression

DMT-SSRI combination shows potential for depression
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

George tzirasCarol routledgeSmall pharma incSmall pharmaChief medicalScientific officerChief executive officer

Small Pharma Inc : Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

Small Pharma Inc : Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergCity ofUnited kingdomCarol routledgeGeorge tzirasJenny maguireCompany or small pharmaVenture exchangeRegulatory agencyRegulation services providerSmall pharma incHead of external affairsMajor depressive disorderSmall pharmaHamilton depression rating scaleMontgomery asberg depression rating

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

• Results suggest that SSRIs enhance the efficacy of SPL026 when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs • At Week 4, 100% of patients in the SSRI.

City ofUnited kingdomGeorge tzirasJenny maguireCarol routledgeHead of external affairsRegulatory agencyCompany or small pharmaRegulation services providerVenture exchangeSmall pharma incMajor depressive disorderSmall pharmaHamilton depression rating scaleMontgomery asberg depression ratingBeck depression inventory

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in

• Results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs

City ofUnited kingdomGeorge tzirasJenny maguireCarol routledgeHead of external affairsSmall pharma incRegulatory agencyCompany or small pharmaMajor depressive disorderSmall pharmaHamilton depression rating scaleMontgomery asberg depression ratingBeck depression inventoryChief medicalScientific officer